A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions

Healthy Participants

Interventions

DRUG

EE/LNG

EE/LNG tablet will be administered orally.

DRUG

Baxdrostat

Baxdrostat tablet will be administered orally.

Trial Locations (1)

Research Site, Brooklyn